These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6820114)

  • 1. Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP.
    Finerman GA; Stover SL
    Metab Bone Dis Relat Res; 1981; 3(4-5):337-42. PubMed ID: 6820114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty.
    Yutani Y; Ohashi H; Nishimura N; Yamano Y
    Osaka City Med J; 1995 Dec; 41(2):63-73. PubMed ID: 8778647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report).
    Stover SL; Hahn HR; Miller JM
    Paraplegia; 1976 Aug; 14(2):146-56. PubMed ID: 823516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients.
    Garland DE; Alday B; Venos KG; Vogt JC
    Clin Orthop Relat Res; 1983 Jun; (176):197-200. PubMed ID: 6406123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of heterotopic ossification and Didronel therapy--regaining wheelchair independence in the spinal cord injured patient.
    Subbarao JV; Nemchausky BA; Gratzer M
    J Am Paraplegia Soc; 1987; 10(1):3-7. PubMed ID: 3106569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury.
    Spielman G; Gennarelli TA; Rogers CR
    Arch Phys Med Rehabil; 1983 Nov; 64(11):539-42. PubMed ID: 6416224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ethylhydroxydiphosphonate (EHDP) on heterotopic ossification.
    Nollen AJ
    Acta Orthop Scand; 1986 Aug; 57(4):358-61. PubMed ID: 3098037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports.
    Biering-Sørensen F; Tøndevold E
    Paraplegia; 1993 Aug; 31(8):513-5. PubMed ID: 8414635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
    Banovac K; Gonzalez F; Wade N; Bowker JJ
    Paraplegia; 1993 Oct; 31(10):660-6. PubMed ID: 8259329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients.
    Stover SL; Niemann KM; Miller JM
    J Bone Joint Surg Am; 1976 Jul; 58(5):683-8. PubMed ID: 819446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudoarthrosis in heterotopic ossification in spinal cord-injured patients.
    Subbarao JV
    Am J Phys Med Rehabil; 1990 Apr; 69(2):88-90. PubMed ID: 2109987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?
    Vasileiadis GI; Sakellariou VI; Kelekis A; Galanos A; Soucacos PN; Papagelopoulos PJ; Babis GC
    J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):159-65. PubMed ID: 20516633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].
    Sauer R; Seegenschmiedt MH; Goldmann A; Beck H; Andreas P
    Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotopic ossification of the hip after spinal cord injury.
    Dai L
    Chin Med J (Engl); 1998 Dec; 111(12):1099-101. PubMed ID: 11263373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of immature heterotopic ossification (HO) of the hip.
    Jamil F; Subbarao JV; Banaovac K; El Masry WS; Bergman SB
    Spinal Cord; 2002 Aug; 40(8):388-95. PubMed ID: 12124665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial.
    Nayak KN; Mulliken B; Rorabeck CH; Bourne RB; Woolfrey MR
    Can J Surg; 1997 Oct; 40(5):368-74. PubMed ID: 9336527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterotopic ossification in poststroke hip fracture: a case report.
    White HC
    J Am Geriatr Soc; 1987 Jul; 35(7):688-91. PubMed ID: 3108352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of calcifications by the use of EHDP after total hip prosthesis operations].
    De Bastiani G; Tarolli G; Bellamoli S
    Chir Organi Mov; 1979; 65(5):525-30. PubMed ID: 122302
    [No Abstract]   [Full Text] [Related]  

  • 19. The suppression of heterotopic ossification after total hip arthroplasty.
    Reis HJ; Küsswetter W; Schellinger T
    Int Orthop; 1992; 16(2):140-5. PubMed ID: 1428312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
    Banovac K
    J Spinal Cord Med; 2000; 23(1):40-4. PubMed ID: 10752873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.